Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man - the use of patient-reported outcome (PRO) measures in oncology studies - Scientific guideline

This document covers general aspects of the use of patient report outcome (PRO) endpoints in oncology studies such as the designing and carrying out of clinical studies, the acceptability of instruments and the clinically important differences and added value.

Keywords: Patient reported outcome (PRO), health related quality of life (HRQL)


How useful was this page?

Add your rating
1 rating